Table 1. Epidemiological characteristics of children and adolescents with SARS-CoV-2 infection in a Brazilian private hospital (n=1303).
Characteristics | n | % | |
---|---|---|---|
Age, years (median, IQR) | 13.0 (7.0–17.0) | ||
0–5 | 273 | 21.0 | |
6–11 | 275 | 21.1 | |
≥12 | 755 | 57.9 | |
Male sex | 642 | 49.3 | |
Indication for testing* | |||
Signs and symptoms of infection | 1203 | 92.3 | |
Contact with a case of COVID-19 | 815 | 62.5 | |
Possible contact with COVID-19 | 117 | 9.0 | |
Other | 13 | 1.0 | |
Time from symptom onset to test, days | 3.0±2.5 | ||
0–3 days | 836 | 64.2 | |
≥4 days | 361 | 27.7 | |
Comorbidities | 122 | 9.4 | |
Asthma | 81 | 6.2 | |
Diabetes | 2 | 0.2 | |
Obesity | 6 | 0.5 | |
Neurologic disorders† | 14 | 1.1 | |
Cardiac diseases‡ | 12 | 0.9 | |
Genetic syndrome§ | 7 | 0.5 | |
Immunosuppression// | 6 | 0.5 |
Results are presented in n (%).
indication for testing was defined by the attending physician;
Neurologic disorders: epilepsy n=9; cerebral palsy n=2; autism n=2; Miastenia gravis n=1;
Cardiac diseases: congenital heart disease n=11; coronary aneurism post Kawasaki disease n=1;
Genetic syndrome: Down syndrome n=3; other rare syndromes n=4;
Immunosuppression: Chron disease n=3; cyclic neutropenia n=1; chemotherapy n=1; juvenile idiopathic arthritis n=1.